47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.43.Z - Wholesale trade of electrical household goods
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,9 | 0,9 | 1,4 | 65,7 |
EBITDA | 1 | 1 | 1,6 | 51,2 |
Short time liabilities | 1,4 | 1,8 | 2 | 12,1 |
Equity capital | 1,7 | 1,5 | 1,5 | -3,7 |
Operating profit (EBIT) | 0,8 | 0,9 | 1,4 | 67,8 |
Assets | 3,1 | 3,3 | 3,4 | 4,8 |
Net profit (loss) | 0,9 | 0,9 | 1,4 | 65,7 |
Cash | 0 | 0,1 | 0,1 | -6,6 |
Liabilities and provisions for liabilities | 1,4 | 1,8 | 2 | 12,1 |
Net income from sale | 13,2 | 15,2 | 17,7 | 16,2 |
Working assets | 1,7 | 1,9 | 2 | 5,9 |
Depreciation | 0,2 | 0,2 | 0,1 | -32,1 |
% | % | % | p.p. | |
Profitability of capital | 53,9 | 58 | 99,7 | 41,7 |
Equity capital to total assets | 53,9 | 46,2 | 42,4 | -3,8 |
Gross profit margin | 6,8 | 5,7 | 8,2 | 2,5 |
EBITDA Margin | 7,9 | 6,8 | 8,8 | 2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 38 | 42 | 41 | -1 |
Current financial liquidity indicator | 1.231147050857544 | 1.0964007377624512 | 1.0359655618667603 | -0,1 |
Net dept to EBITDA | 0.017055727541446686 | -0.11635230481624603 | -0.07185201346874237 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane